107 related articles for article (PubMed ID: 35698008)
1. Association of gene mutations with clinicopathologic features in patients with external auditory canal squamous cell carcinoma.
Morita S; Kano S; Hatanaka KC; Hatanaka Y; Suzuki T; Fukuda A; Hoshino K; Fujiwara K; Nakamaru Y; Homma A
Int J Clin Oncol; 2022 Sep; 27(9):1394-1403. PubMed ID: 35698008
[TBL] [Abstract][Full Text] [Related]
2. Genetic landscape of external auditory canal squamous cell carcinoma.
Sato K; Komune N; Hongo T; Koike K; Niida A; Uchi R; Noda T; Kogo R; Matsumoto N; Yamamoto H; Masuda M; Oda Y; Mimori K; Nakagawa T
Cancer Sci; 2020 Aug; 111(8):3010-3019. PubMed ID: 32500594
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma.
Liu H; Dai C; Wu Q; Liu H; Li F
Cancer Med; 2017 Nov; 6(11):2541-2551. PubMed ID: 28960885
[TBL] [Abstract][Full Text] [Related]
4. Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2.
Komune N; Sato K; Ono M; Imaizumi A; Masuda S; Itoyama S; Manako T; Kuga R; Hongo T; Kogo R; Onishi H; Nakagawa T
Sci Rep; 2023 Nov; 13(1):19636. PubMed ID: 37949965
[TBL] [Abstract][Full Text] [Related]
5. miR-34a predicts the prognosis of advanced-stage external auditory canal squamous cell carcinoma.
Akiyama N; Yamamoto-Fukuda T; Kojima H
Acta Otolaryngol; 2022 Jun; 142(6):537-541. PubMed ID: 35732008
[TBL] [Abstract][Full Text] [Related]
6. Expression of EGFR and p16 in Squamous Cell Carcinoma of External Auditory Canal.
Kajimoto Y; Shinomiya H; Uehara N; Teshima M; Fujita T; Kakigi A; Imamura Y; Kiyota N; Miyawaki D; Sasaki R; Kimura H; Nibu KI
Kobe J Med Sci; 2024 Jan; 69(4):E144-E150. PubMed ID: 38379276
[TBL] [Abstract][Full Text] [Related]
7. Surgery With or Without Postoperative Radiation Therapy for Early-stage External Auditory Canal Squamous Cell Carcinoma: A Meta-analysis.
Oya R; Takenaka Y; Takemura K; Ashida N; Shimizu K; Kitamura T; Yamamoto Y; Uno A
Otol Neurotol; 2017 Oct; 38(9):1333-1338. PubMed ID: 28796084
[TBL] [Abstract][Full Text] [Related]
8. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376
[TBL] [Abstract][Full Text] [Related]
10. Right dominance in the incidence of external auditory canal squamous cell carcinoma in the Japanese population: Does handedness affect carcinogenesis?
Tsunoda A; Sumi T; Terasaki O; Kishimoto S
Laryngoscope Investig Otolaryngol; 2017 Feb; 2(1):19-22. PubMed ID: 28894818
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.
Omura G; Ando M; Ebihara Y; Saito Y; Kobayashi K; Fukuoka O; Akashi K; Yoshida M; Asakage T; Yamasoba T
BMC Cancer; 2017 Dec; 17(1):898. PubMed ID: 29282038
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of temporal bone squamous cell carcinoma: A single-institution experience.
Zheng Y; Qiu K; Fu Y; Yang W; Cheng D; Rao Y; Mao M; Song Y; Xu W; Ren J; Zhao Y
Cancer Med; 2023 Mar; 12(5):5304-5311. PubMed ID: 36229984
[TBL] [Abstract][Full Text] [Related]
14. Targeted Genomic Sequencing Reveals Novel
Jung YY; Woo HY; Kim HS
Anticancer Res; 2019 Jun; 39(6):2883-2889. PubMed ID: 31177126
[TBL] [Abstract][Full Text] [Related]
15. Survival prediction model for non-small cell lung cancer based on somatic mutations.
Zhang W; Lin X; Li X; Wang M; Sun W; Han X; Sun D
J Gene Med; 2020 Sep; 22(9):e3206. PubMed ID: 32367667
[TBL] [Abstract][Full Text] [Related]
16. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
[TBL] [Abstract][Full Text] [Related]
17. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.
Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T
Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104
[TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
[TBL] [Abstract][Full Text] [Related]
19. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
[TBL] [Abstract][Full Text] [Related]
20. Implication of cytoplasmic p53 expression in pulmonary neuroendocrine carcinoma using next-generation sequencing analysis.
Jimbo N; Ohbayashi C; Fujii T; Takeda M; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
Histopathology; 2024 Jan; 84(2):336-342. PubMed ID: 37814580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
